image: CSIRO's biomedical imaging team is developing image processing algorithms to characterize Alzheimer's disease using quantitative biomarkers. Here a method to compute cortical thickness (color coded) shows how the disease induces atrophy in two typical participants of the AIBL study. view more
Credit: AIBL
The leader of dementia research in CSIRO's Preventative Health National Research Flagship, Dr Cassandra Szoeke, says the report highlights the challenge the nation faces with the number dementia sufferers predicted to double to 465,000 by 2030.
"About 80 per cent of dementia in Australia is caused by Alzheimer's disease," Dr Szoeke, says. "Early diagnosis is crucial if we are to begin managing this crisis more effectively."
"By the time sufferers show symptoms of memory loss, severe irreversible brain cell death may have already occurred."
"In Australia every week another 1000 people are being diagnosed with dementia. It is only by early diagnosis that treatment can be effective, preserving memory and brain."
"With the initiation of the AIBL (Australian Imaging, Biomarker and Lifestyle) cluster study the combined institutions have potentially brought forward the detection of Alzheimer's disease by 18 months," Dr Szoeke says.
"Early detection can not only aid with future treatment options but it can also help with the planning and delivery of dementia care services in Australia."
Released earlier this week, the Access Economics report also found that investment in dementia research is a key strategy for addressing the epidemic.
"There is no question that research is the key to reducing the burden of the disease on the community for the future and CSIRO and its partners will continue to seek effective, new approaches to prevention, diagnosis and treatment of these diseases," Dr Szoeke says.
* The Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing is a collaboration initiated by the CSIRO Preventative Health National Research Flagship. AIBL is a joint activity between the Flagship, the University of Melbourne, Edith Cowan University - Western Australia, Neurosciences Australia, the Mental Health Research Institute of Victoria and the National Ageing Research Institute.
National Research Flagships
CSIRO initiated the National Research Flagships to provide science-based solutions in response to Australia's major research challenges and opportunities. The nine Flagships form multidisciplinary teams with industry and the research community to deliver impact and benefits for Australia.
Image available at: http://www.scienceimage.csiro.au/mediarelease/mr09-78.html
Further Information:
Dr Cassandra Szoeke, CSIRO Preventative Health Flagship
Mb: 0409 039 533
E: Cassandra.Szoeke@csiro.au
Media Assistance:
Kelly Golding, CSIRO Preventative Health Flagship
Mb:+61 401 297 984
E: Kelly.Golding@csiro.au